IN2014DN03010A - - Google Patents

Info

Publication number
IN2014DN03010A
IN2014DN03010A IN3010DEN2014A IN2014DN03010A IN 2014DN03010 A IN2014DN03010 A IN 2014DN03010A IN 3010DEN2014 A IN3010DEN2014 A IN 3010DEN2014A IN 2014DN03010 A IN2014DN03010 A IN 2014DN03010A
Authority
IN
India
Prior art keywords
compounds
methods
compositions
administering
producing
Prior art date
Application number
Other languages
English (en)
Inventor
Maxime Gualtieri
Guillot Philippe Villain
Alain Givaudan
Sylvie Pages
Original Assignee
Nosopharm
Agronomique Inst Nat Rech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nosopharm, Agronomique Inst Nat Rech filed Critical Nosopharm
Publication of IN2014DN03010A publication Critical patent/IN2014DN03010A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IN3010DEN2014 2011-09-28 2012-09-28 IN2014DN03010A (uk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161540085P 2011-09-28 2011-09-28
EP11183034 2011-09-28
PCT/EP2012/069166 WO2013045600A1 (en) 2011-09-28 2012-09-28 Novel peptide derivatives as antibiotics

Publications (1)

Publication Number Publication Date
IN2014DN03010A true IN2014DN03010A (uk) 2015-05-08

Family

ID=47994311

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3010DEN2014 IN2014DN03010A (uk) 2011-09-28 2012-09-28

Country Status (10)

Country Link
US (1) US9260481B2 (uk)
EP (1) EP2760881B1 (uk)
JP (1) JP6158188B2 (uk)
CN (1) CN103827138B (uk)
CA (1) CA2845735A1 (uk)
ES (1) ES2657930T3 (uk)
IL (1) IL231664A0 (uk)
IN (1) IN2014DN03010A (uk)
RU (1) RU2014114996A (uk)
WO (1) WO2013045600A1 (uk)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3197908A1 (en) * 2014-09-26 2017-08-02 Nosopharm Novel peptide derivatives and uses thereof
US9800971B2 (en) 2015-03-17 2017-10-24 Knowles Electronics, Llc Acoustic apparatus with side port
US11667674B2 (en) 2016-04-08 2023-06-06 Versitech Limited Antibacterial cyclic lipopeptides
US10647746B2 (en) 2016-04-08 2020-05-12 Versitech Limited Antibacterial cyclic lipopeptides
WO2024200838A1 (en) * 2023-03-31 2024-10-03 Nosopharm New odilorhabdins analogues as antibiotics against multi-resistant bacteria

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8717299D0 (en) * 1987-07-22 1987-08-26 Nat Res Dev Peptides
FR2819514B1 (fr) * 2001-01-12 2003-02-28 Rhobio Pseudopeptides antimicrobiens
US20110033389A1 (en) * 2009-04-29 2011-02-10 Zhifeng Chen Modified antibodies for passive immunotherapy
FR2946058A1 (fr) * 2009-05-27 2010-12-03 Nosopharm Procede pour augmenter la diversite des metabolites secondaires d'interet produits par des micro-organismes

Also Published As

Publication number Publication date
CA2845735A1 (en) 2013-04-04
EP2760881B1 (en) 2017-11-01
IL231664A0 (en) 2014-05-28
RU2014114996A (ru) 2015-11-10
CN103827138A (zh) 2014-05-28
JP6158188B2 (ja) 2017-07-05
CN103827138B (zh) 2016-05-25
US9260481B2 (en) 2016-02-16
US20150175659A1 (en) 2015-06-25
WO2013045600A1 (en) 2013-04-04
JP2014534173A (ja) 2014-12-18
EP2760881A1 (en) 2014-08-06
ES2657930T3 (es) 2018-03-07

Similar Documents

Publication Publication Date Title
IN2014MN00948A (uk)
MD20150091A2 (ro) Compuşi antivirali
IN2014MN00987A (uk)
TN2015000278A1 (en) Autotaxin inhibitors
IN2014MN00988A (uk)
IN2014MN02049A (uk)
IN2014MN00986A (uk)
IN2014MN02069A (uk)
EP2872151A4 (en) ACELLULAR PRO-TOLEROGENIC COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF AUTOIMMUNE DISEASES
PH12014501514A1 (en) New azetidine derivatives, pharmaceutical compositions and uses thereof
PH12015501609A1 (en) Phenicol antibacterials
IN2015DN01119A (uk)
MX353299B (es) Metodos y composiciones relacionadas con p62 para el tratamiento y profilaxis del cancer.
IN2015DN01151A (uk)
MX349224B (es) Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa.
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
SG10201900541QA (en) Derivatives of xanthone compounds
IN2014DN03010A (uk)
MX347541B (es) Analogos de acido sialico.
PH12014502065A1 (en) Vesicular formulations
NZ707773A (en) Methods of treating liver diseases
EP2785335B8 (en) Methods and pharmaceutical compositions for the treatment of darier disease
IN2015DN02109A (uk)
MX2013003859A (es) Polimorfos de picropodofilina b o c para su uso en la terapia del cancer.
MX2014004742A (es) Nuevos agentes antibacterianos de fenicol.